If 1,000 men ages 55 to 69 get screened with a PSA test every year for 13 years, research shows about 1.3 fewer of them will die from prostate cancer compared to men who are not screened. In that same group, about 240 men will get a false-positive result, about 100 will be diagnosed with prostate cancer, and about 80 will be treated — often with side effects like erectile dysfunction or urinary incontinence. This is the real trade-off behind the screening debate: a small chance of a life saved against a much larger chance of unnecessary worry, biopsies, or treatment for a cancer that may never have caused harm.
See a Doctor Promptly If You Notice These Symptoms
Most early prostate cancer causes no symptoms at all, which is exactly why the screening debate exists. But some symptoms should never wait for a routine screening conversation. Contact your doctor promptly if you have blood in your urine or semen, or pain in your back, hips, or pelvis that doesn’t go away. Frequent or sudden urges to urinate, a weak urine stream, pain while urinating, or painful ejaculation can also signal a prostate problem and are worth mentioning at your next visit, even though these are more often caused by non-cancer conditions like an enlarged prostate. Fever, chills, and burning urination together can signal a prostate infection that needs care right away.
What a PSA Test Actually Measures
The PSA test measures the level of prostate-specific antigen, a protein made by both normal and cancerous prostate cells, in your blood. It is not a cancer test by itself — it’s a signal that something in the prostate may need a closer look. A result above 4.0 nanograms per milliliter is generally considered high, though many doctors use different cutoffs depending on your age.
A high PSA does not mean you have cancer. Elevated levels are commonly caused by an enlarged prostate, a prostate infection, a recent biopsy, vigorous exercise like cycling, or recent ejaculation. Because of this, about 6% to 7% of men will get a false-positive PSA result on any given screening round. Of the men who go on to have a biopsy because of a high PSA, only about 1 in 4 actually turn out to have prostate cancer.
The Official Guidelines, By Age
The U.S. Preventive Services Task Force (USPSTF) is the government-backed panel that sets the standard for cancer screening guidance. Its current recommendation splits by age:
- Under 55: There isn’t enough evidence to make a blanket recommendation for or against screening at this age.
- 55 to 69: Screening should be an individual decision. The USPSTF gives this a “Grade C” recommendation, meaning the choice should come from a conversation with your doctor about your personal risk and values, not a routine, automatic test.
- 70 and older: The USPSTF recommends against routine PSA screening. At this age, the potential harms are judged to generally outweigh the potential benefit.
The National Cancer Institute, the federal government’s main cancer research agency, echoes this: screening remains genuinely controversial because it has not been clearly shown to reduce prostate cancer deaths across the board, even though it can catch some aggressive cancers earlier.
Why Doctors Disagree: Overdiagnosis and Overtreatment
The core of the debate comes down to one fact: many prostate cancers grow so slowly they would never cause symptoms or shorten a man’s life, even without treatment. When a screening test finds one of these slow-growing cancers, it’s called overdiagnosis. The problem is that doctors currently can’t always tell, at the time of diagnosis, which cancers are dangerous and which aren’t.
That uncertainty leads to overtreatment — surgery, radiation, or other treatment for a cancer that may never have needed it. Treatment side effects are common and can be permanent, most often erectile dysfunction and urinary incontinence. Biopsies themselves also carry risk, including fever, pain, blood in the urine or semen, and urinary tract infection.
Who Might Weigh This Differently
The USPSTF notes that older age, African American race, and a family history of prostate cancer are the most important risk factors for the disease. Its guidance says men and their doctors should factor in family history, race and ethnicity, other health conditions, and personal values about the benefits and harms of screening and treatment when deciding what to do between ages 55 and 69. This doesn’t change the official age range, but it’s a reason some men choose to have this conversation with their doctor earlier rather than later.
A Decision Worksheet for Your Next Doctor Visit
Since this is meant to be an individual decision, not a default test, it helps to walk in prepared. Consider bringing these questions:
- Based on my age, race, and family history, what is my personal risk of prostate cancer?
- If my PSA comes back high, what would the next steps look like, and what are the risks of those steps?
- If a cancer is found, how would we know whether it needs treatment or can be safely watched?
- What are my own feelings about living with uncertainty versus the risk of overtreatment?
- Given my personal risk and values, does it make sense for me to screen now, wait, or skip it?
There is no universally correct answer. The right choice depends on your risk factors, your health history, and how you personally weigh a small chance of benefit against a real chance of unnecessary treatment.
Frequently Asked Questions
Is the PSA test required at a certain age?
No. There is no age at which PSA screening is required. For ages 55 to 69, it’s a personal decision made with your doctor. For men 70 and older, routine screening is generally not recommended.
Can a high PSA mean something other than cancer?
Yes. An enlarged prostate, a prostate infection, a recent biopsy, vigorous exercise, or recent ejaculation can all raise PSA levels. Most men with a high PSA do not have prostate cancer.
Do supplements lower PSA or prevent prostate cancer?
No supplement has been shown to prevent prostate cancer or reliably lower PSA in a way that changes screening decisions. If you’re taking or considering a prostate supplement, our evidence-based guide to prostate health supplements and our review of saw palmetto clinical trial evidence break down what the research actually supports.
What’s the difference between a PSA test and a DRE?
They’re two different screening tools that are sometimes used together. See our full comparison in PSA and DRE Results: What Screening Tests Can and Cannot Tell You for what each one can and can’t show.
This article is for general education only and is not medical advice. It does not diagnose any condition or recommend a specific screening schedule, test, or treatment for you personally. Talk with a qualified doctor about your own prostate cancer risk and whether PSA screening is right for you. If you’re evaluating a prostate supplement, our prostate supplement safety guide covers when supplementation makes sense and when it’s time to see a urologist instead.